Home>Topics>>Express Scripts scales back coverage of compounded meds
Express Scripts scales back coverage of compounded meds
SeekingAlpha.com: SA Currents
Thu, 3 Jul 2014
Saying that most custom-mixed medicines are either ineffective or overpriced, pharmacy benefit manager Express Scripts ( ESRX +0.6% ) plans to drop coverage for 1,000 drug ingredients found in compounded meds. The company states that the move will reduce employers' spending on compounded ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.